Birchview Capital as of June 30, 2026
Portfolio Holdings for Birchview Capital
Birchview Capital holds 72 positions in its portfolio as reported in the June 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kla Corporation Com New (KLAC) | 25.2 | $54M | 179k | 301.71 | |
| Bristol Myers Squibb (BMY) | 8.0 | $17M | 297k | 57.62 | |
| Lam Research Corporation Com New (LRCX) | 7.1 | $15M | 35k | 433.33 | |
| Solid Biosciences Com New (SLDB) | 3.1 | $6.7M | 666k | 9.99 | |
| Intellia Therapeutics (NTLA) | 3.1 | $6.5M | 386k | 16.92 | |
| Biodesix | 3.0 | $6.5M | 287k | 22.55 | |
| Stoke Therapeutics (STOK) | 2.7 | $5.8M | 178k | 32.72 | |
| Encana Corporation (OVV) | 2.7 | $5.7M | 108k | 52.65 | |
| Nektar Therapeutics (NKTR) | 2.6 | $5.7M | 81k | 69.81 | |
| Corcept Therapeutics Incorporated (CORT) | 2.3 | $5.0M | 57k | 86.95 | |
| Neurocrine Biosciences (NBIX) | 2.1 | $4.6M | 27k | 168.53 | |
| Prothena Corp SHS (PRTA) | 2.1 | $4.4M | 449k | 9.79 | |
| ACADIA Pharmaceuticals (ACAD) | 2.0 | $4.3M | 171k | 25.30 | |
| Protagonist Therapeutics (PTGX) | 2.0 | $4.3M | 35k | 122.58 | |
| Compass Therapeutics (CMPX) | 1.7 | $3.7M | 1.7M | 2.19 | |
| Relmada Therapeutics (RLMD) | 1.3 | $2.8M | 408k | 6.92 | |
| Alkermes SHS (ALKS) | 1.2 | $2.6M | 50k | 52.40 | |
| Halozyme Therapeutics (HALO) | 1.2 | $2.6M | 33k | 78.27 | |
| Celldex Therapeutics Com New (CLDX) | 1.2 | $2.6M | 70k | 37.21 | |
| Cytokinetics (CYTK) | 1.2 | $2.6M | 30k | 85.19 | |
| Olema Pharmaceuticals (OLMA) | 1.2 | $2.5M | 199k | 12.51 | |
| Vera Therapeutics Cl A (VERA) | 1.2 | $2.5M | 58k | 42.91 | |
| United Therapeutics Corporation (UTHR) | 1.1 | $2.4M | 4.5k | 541.83 | |
| Zenas Biopharma (ZBIO) | 1.1 | $2.4M | 94k | 25.38 | |
| Uniqure Nv SHS (QURE) | 1.1 | $2.3M | 51k | 46.06 | |
| Pacific Biosciences of California (PACB) | 1.1 | $2.3M | 1.4M | 1.68 | |
| Abivax Sa Sponsored Ads (ABVX) | 1.1 | $2.3M | 17k | 133.26 | |
| Vir Biotechnology (VIR) | 1.0 | $2.2M | 220k | 10.19 | |
| Biogen Idec (BIIB) | 0.9 | $1.9M | 9.0k | 216.06 | |
| EQT Corporation (EQT) | 0.9 | $1.8M | 35k | 53.17 | |
| Bioage Labs (BIOA) | 0.8 | $1.7M | 69k | 24.51 | |
| Travere Therapeutics (TVTX) | 0.8 | $1.6M | 29k | 56.81 | |
| Quidel Corporation | 0.7 | $1.6M | 89k | 17.52 | |
| Axsome Therapeutics (AXSM) | 0.7 | $1.5M | 6.0k | 244.77 | |
| Foghorn Therapeutics (FHTX) | 0.6 | $1.4M | 282k | 4.88 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 0.6 | $1.3M | 314k | 4.24 | |
| Structure Therapeutics Spons Adr (GPCR) | 0.6 | $1.3M | 24k | 53.67 | |
| Xenon Pharmaceuticals (XENE) | 0.6 | $1.3M | 21k | 60.36 | |
| Novo Nordisk A/s Adr (NVO) | 0.5 | $1.2M | 24k | 47.94 | |
| Freeport-mcmoran Cl-b CL-B (FCX) | 0.5 | $1.1M | 18k | 62.89 | |
| Immunome (IMNM) | 0.5 | $1.1M | 50k | 21.19 | |
| Pharvaris N V (PHVS) | 0.5 | $1.0M | 30k | 34.58 | |
| Harrow Health (HROW) | 0.5 | $1.0M | 24k | 42.47 | |
| Adagene Ads (ADAG) | 0.5 | $1.0M | 240k | 4.20 | |
| Definium Therapeutics Com Shs (DFTX) | 0.4 | $941k | 20k | 47.04 | |
| Silence Therapeutics Ads (SLN) | 0.4 | $782k | 71k | 10.98 | |
| Bridgebio Pharma (BBIO) | 0.3 | $651k | 8.7k | 74.48 | |
| 4d Molecular Therapeutics In (FDMT) | 0.3 | $645k | 49k | 13.30 | |
| Urogen Pharma (URGN) | 0.3 | $607k | 17k | 36.80 | |
| Phathom Pharmaceuticals (PHAT) | 0.3 | $597k | 55k | 10.85 | |
| Camp4 Therapeutics Corp (CAMP) | 0.2 | $524k | 120k | 4.37 | |
| Savara (SVRA) | 0.2 | $493k | 80k | 6.16 | |
| Candel Therapeutics (CADL) | 0.2 | $492k | 48k | 10.30 | |
| Altimmune Com New (ALT) | 0.2 | $464k | 153k | 3.04 | |
| Compass Pathways Sponsored Ads (CMPS) | 0.2 | $425k | 30k | 14.15 | |
| Karyopharm Therapeutics | 0.2 | $420k | 43k | 9.77 | |
| Cullinan Oncology (CGEM) | 0.2 | $364k | 20k | 18.21 | |
| Trinity Cap (TRIN) | 0.2 | $358k | 20k | 17.89 | |
| Capricor Therapeutics Com New (CAPR) | 0.2 | $346k | 14k | 24.08 | |
| Castle Biosciences (CSTL) | 0.1 | $310k | 13k | 23.85 | |
| Adagio Therapeutics (IVVD) | 0.1 | $299k | 342k | 0.87 | |
| Acasti Pharma (GRCE) | 0.1 | $272k | 120k | 2.27 | |
| Kayne Anderson Bdc Com Shs (KBDC) | 0.1 | $271k | 20k | 13.53 | |
| Voyager Therapeutics (VYGR) | 0.1 | $263k | 75k | 3.50 | |
| Pulmonx Corp (LUNG) | 0.1 | $261k | 201k | 1.30 | |
| Ocular Therapeutix (OCUL) | 0.1 | $203k | 21k | 9.82 | |
| Kyntra Bio Com New (KYNB) | 0.1 | $170k | 23k | 7.55 | |
| Aziyo Biologics (ELUT) | 0.1 | $162k | 165k | 0.98 | |
| Quoin Pharmaceuticals Sponsored Ads (QNRX) | 0.0 | $97k | 20k | 4.84 | |
| Lipocine Com New (LPCN) | 0.0 | $43k | 17k | 2.56 | |
| Docgo (DCGO) | 0.0 | $20k | 39k | 0.52 | |
| Gossamer Bio (GOSS) | 0.0 | $3.0k | 18k | 0.16 |